Addressing vaccine stability and cold chain challenges with recombinant human serum albumin to enable global administration

Authors

• Mark Stathos, InVitria Inc, USAFollow
• Cameron Martin PhD, Scientist
• Pratik Katwal PhD, Scientist III
• Elliott Renft, Director, Product Applications

Conference Dates

May 19 - 24, 2024

Abstract

Please click Additional Files below to see the full abstract.

Recommended Citation

Mark Stathos; Cameron Martin PhD; Pratik Katwal PhD; and Elliott Renft, Director, "Addressing vaccine stability and cold chain challenges with recombinant human serum albumin to enable global administration" in "Vaccine Technology IX", Linda Lua, The University of Queensland, Australia; Charles Lutsch, Sanofi-Vaccines, France; Francesc Gòdia, Universitat Autònoma de Barcelona (UAB), Spain; Tara Tagmyer, CMC Leader, USA Eds, ECI Symposium Series, (2024). https://dc.engconfintl.org/vaccine_ix/12